Changes in Intestinal Microbiota and Their Relationship With Patient Characteristics in Colorectal Cancer.

IF 1.9 4区 医学 Q3 ONCOLOGY
Clinical Medicine Insights-Oncology Pub Date : 2024-12-24 eCollection Date: 2024-01-01 DOI:10.1177/11795549241307632
Lu Zhao, Yongkun Fang, Jingqiu Zhang, Chen Wei, Hao Ji, Jiahao Zhao, Daorong Wang, Dong Tang
{"title":"Changes in Intestinal Microbiota and Their Relationship With Patient Characteristics in Colorectal Cancer.","authors":"Lu Zhao, Yongkun Fang, Jingqiu Zhang, Chen Wei, Hao Ji, Jiahao Zhao, Daorong Wang, Dong Tang","doi":"10.1177/11795549241307632","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Gut microbiota are associated with the pathological features and development of colorectal cancer (CRC); however, how gut microbiota changes in patients with CRC is unknown. This study investigated the role of gut microbiota in the development and progression of CRC by retrospectively comparing the structural differences between the gut microbiota of patients with CRC and healthy individuals.</p><p><strong>Methods: </strong>Together with clinical data, we collected fecal samples from patients with CRC (n = 18) and healthy controls (n = 18) and performed 16S rRNA gene sequencing and alpha and beta diversity analysis to compare microbiota richness and diversity. Based on the differences in microbiota between the CRC and control groups, we identified disease-specific microbial communities after relevant factors. PICRUSt2 software was used to predict the differential microbial functions.</p><p><strong>Results: </strong>The CRC and control groups differed in both composition and abundance of intestinal microbiota. Firmicutes and Bacteroidetes were the most abundant phyla in both groups, while Verrucomicrobi was significantly more abundant in the CRC group. <i>Megamonas</i>, <i>Lachnospira</i>, and <i>Romboutsia</i> were more abundant in the control group; 18 genera differed significantly in abundance between the groups, which were found to involve 21 metabolic pathways. The distribution and abundance of gut microbiota differed significantly between patients with CRC with and without lymph node metastasis; at the genus level, the abundance of <i>Rothia</i> and <i>Streptococcus</i> was significantly higher and that of <i>Bacteroides</i>, <i>Parabacteroides</i>, and <i>Oscillibacter</i> was significantly lower in patients with lymph node metastasis.</p><p><strong>Conclusions: </strong>The gut microbiota is altered in CRC patients compared with healthy individuals, with specific changes in the microbiota associated with clinical and pathological features such as tumor stage, lymph node involvement, and tumor differentiation. Our findings elaborate to some extent on the link between the gut microbiota and CRC.</p>","PeriodicalId":48591,"journal":{"name":"Clinical Medicine Insights-Oncology","volume":"18 ","pages":"11795549241307632"},"PeriodicalIF":1.9000,"publicationDate":"2024-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11672582/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Medicine Insights-Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/11795549241307632","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Gut microbiota are associated with the pathological features and development of colorectal cancer (CRC); however, how gut microbiota changes in patients with CRC is unknown. This study investigated the role of gut microbiota in the development and progression of CRC by retrospectively comparing the structural differences between the gut microbiota of patients with CRC and healthy individuals.

Methods: Together with clinical data, we collected fecal samples from patients with CRC (n = 18) and healthy controls (n = 18) and performed 16S rRNA gene sequencing and alpha and beta diversity analysis to compare microbiota richness and diversity. Based on the differences in microbiota between the CRC and control groups, we identified disease-specific microbial communities after relevant factors. PICRUSt2 software was used to predict the differential microbial functions.

Results: The CRC and control groups differed in both composition and abundance of intestinal microbiota. Firmicutes and Bacteroidetes were the most abundant phyla in both groups, while Verrucomicrobi was significantly more abundant in the CRC group. Megamonas, Lachnospira, and Romboutsia were more abundant in the control group; 18 genera differed significantly in abundance between the groups, which were found to involve 21 metabolic pathways. The distribution and abundance of gut microbiota differed significantly between patients with CRC with and without lymph node metastasis; at the genus level, the abundance of Rothia and Streptococcus was significantly higher and that of Bacteroides, Parabacteroides, and Oscillibacter was significantly lower in patients with lymph node metastasis.

Conclusions: The gut microbiota is altered in CRC patients compared with healthy individuals, with specific changes in the microbiota associated with clinical and pathological features such as tumor stage, lymph node involvement, and tumor differentiation. Our findings elaborate to some extent on the link between the gut microbiota and CRC.

结直肠癌患者肠道菌群变化及其与患者特征的关系
背景:肠道微生物群与结直肠癌(CRC)的病理特征和发展有关;然而,结直肠癌患者肠道菌群如何变化尚不清楚。本研究通过回顾性比较结直肠癌患者和健康人肠道菌群的结构差异,探讨肠道菌群在结直肠癌发生和进展中的作用。方法:结合临床资料,收集结直肠癌患者(n = 18)和健康对照(n = 18)的粪便样本,进行16S rRNA基因测序和α和β多样性分析,比较微生物群的丰富度和多样性。基于结直肠癌组和对照组之间微生物群的差异,我们在相关因素后确定了疾病特异性微生物群落。PICRUSt2软件预测微生物功能差异。结果:结直肠癌组和对照组在肠道菌群的组成和丰度上都存在差异。厚壁菌门(Firmicutes)和拟杆菌门(Bacteroidetes)在两组中都是最丰富的门,而Verrucomicrobi在CRC组中明显更丰富。对照组中巨单胞菌、毛螺旋体和Romboutsia数量较多;18个属在组间丰度差异显著,涉及21种代谢途径。有无淋巴结转移的结直肠癌患者肠道菌群的分布和丰度存在显著差异;在属水平上,淋巴结转移患者中罗氏菌属和链球菌的丰度显著较高,拟杆菌属、拟副杆菌属和Oscillibacter的丰度显著较低。结论:与健康个体相比,结直肠癌患者的肠道微生物群发生了改变,微生物群的具体变化与肿瘤分期、淋巴结受累和肿瘤分化等临床和病理特征相关。我们的研究结果在一定程度上阐述了肠道微生物群与结直肠癌之间的联系。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.40
自引率
4.50%
发文量
57
审稿时长
8 weeks
期刊介绍: Clinical Medicine Insights: Oncology is an international, peer-reviewed, open access journal that focuses on all aspects of cancer research and treatment, in addition to related genetic, pathophysiological and epidemiological topics. Of particular but not exclusive importance are molecular biology, clinical interventions, controlled trials, therapeutics, pharmacology and drug delivery, and techniques of cancer surgery. The journal welcomes unsolicited article proposals.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信